X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2793) 2793
Book Review (472) 472
Publication (154) 154
Newsletter (12) 12
Conference Proceeding (9) 9
Book Chapter (8) 8
Magazine Article (8) 8
Trade Publication Article (2) 2
Book / eBook (1) 1
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2276) 2276
index medicus (2120) 2120
sertraline (1876) 1876
female (1467) 1467
psychiatry (1396) 1396
male (1385) 1385
adult (1100) 1100
middle aged (881) 881
serotonin uptake inhibitors - therapeutic use (793) 793
pharmacology & pharmacy (769) 769
serotonin uptake inhibitors - adverse effects (768) 768
sertraline - therapeutic use (720) 720
fluoxetine (706) 706
antidepressants (684) 684
treatment outcome (682) 682
sertraline - adverse effects (608) 608
double-blind (580) 580
aged (569) 569
depression (546) 546
antidepressive agents - therapeutic use (535) 535
depressive disorder - drug therapy (515) 515
paroxetine (498) 498
double-blind method (449) 449
antidepressive agents - adverse effects (423) 423
clinical neurology (407) 407
adolescent (378) 378
neurosciences (371) 371
drug therapy (370) 370
major depression (352) 352
depressive disorder, major - drug therapy (343) 343
serotonin reuptake inhibitors (326) 326
efficacy (308) 308
psychiatric status rating scales (288) 288
1-naphthylamine - analogs & derivatives (278) 278
dose-response relationship, drug (273) 273
depression, mental (260) 260
serotonin (249) 249
placebo (245) 245
depression - drug therapy (242) 242
abridged index medicus (239) 239
psychology, clinical (234) 234
serotonin uptake inhibitors (229) 229
serotonin uptake inhibitors - administration & dosage (221) 221
citalopram (219) 219
sertraline - administration & dosage (216) 216
major depressive disorder (215) 215
care and treatment (213) 213
fluvoxamine (206) 206
mental depression (206) 206
1-naphthylamine - adverse effects (204) 204
clinical trials (196) 196
child (193) 193
drug administration schedule (188) 188
antidepressive agents, second-generation - therapeutic use (182) 182
depressive disorder - psychology (181) 181
risk factors (178) 178
drug therapy, combination (177) 177
antidepressive agents, second-generation - adverse effects (175) 175
drug interactions (174) 174
fluoxetine - therapeutic use (173) 173
research (173) 173
paroxetine - adverse effects (170) 170
paroxetine - therapeutic use (169) 169
medicine, general & internal (168) 168
analysis (167) 167
placebo-controlled trial (165) 165
serotonin uptake inhibitors - pharmacology (164) 164
medicine & public health (163) 163
comorbidity (162) 162
antidepressant (157) 157
pharmacotherapy (155) 155
fluoxetine - adverse effects (153) 153
venlafaxine (151) 151
young adult (150) 150
aged, 80 and over (147) 147
animals (144) 144
time factors (144) 144
obsessive-compulsive disorder (142) 142
dosage and administration (141) 141
drugs (138) 138
anxiety (137) 137
1-naphthylamine - therapeutic use (136) 136
symptoms (136) 136
pediatrics (134) 134
disorder (133) 133
citalopram - therapeutic use (130) 130
randomized controlled trials as topic (129) 129
severity of illness index (129) 129
antidepressive agents - administration & dosage (128) 128
follow-up studies (128) 128
children (126) 126
health aspects (122) 122
sertraline - pharmacology (122) 122
ssris (121) 121
metaanalysis (120) 120
selective serotonin reuptake inhibitors (120) 120
placebos (119) 119
complications and side effects (118) 118
venlafaxine hydrochloride (118) 118
prevalence (117) 117
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2723) 2723
Spanish (24) 24
French (22) 22
German (13) 13
Russian (8) 8
Dutch (4) 4
Japanese (4) 4
Swedish (4) 4
Danish (3) 3
Norwegian (3) 3
Turkish (3) 3
Chinese (2) 2
Polish (2) 2
Serbian (2) 2
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
EMBO Reports, ISSN 1469-221X, 10/2017, Volume 18, Issue 10, pp. 1688 - 1692
Journal Article
Journal Article
Neuropsychiatric Disease and Treatment, ISSN 1176-6328, 05/2016, Volume 12, pp. 1127 - 1129
Sertraline has been considered to be a relatively safe selective serotonin reuptake inhibitor for adolescents for a long time. We report herein a case of a... 
Extrapyramidal symptoms | Selective serotonin reuptake inhibitors | Adolescents | Sertraline | Child psychopathology | Cytochrome | Dopamine | Serotonin | Mental disorders | Hematology | Mental health | Patients | Medicine | Hospitals | Sodium | Antidepressants | Rabies | Teenagers | Psychiatry | Drug dosages
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. 1078 - 1089
Background & Aims We performed a genome-wide association study (GWAS) to identify genetic risk factors for drug-induced liver injury (DILI) from licensed drugs... 
Gastroenterology and Hepatology | Side Effect | Medication | Liver Damage | Anti-Fungal Agent | POPULATION | SUSCEPTIBILITY | RISK | TERBINAFINE | TICLOPIDINE | HEPATITIS | CLASS-I | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | ANTIGEN | Antifungal Agents - adverse effects | Naphthalenes - adverse effects | Humans | Middle Aged | Male | Sertraline - adverse effects | Fenofibrate - adverse effects | Chromosomes, Human, Pair 2 - genetics | Ticlopidine - adverse effects | Female | Odds Ratio | Chemical and Drug Induced Liver Injury - etiology | Platelet Aggregation Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Genes, MHC Class I - genetics | Chemical and Drug Induced Liver Injury - genetics | Terbinafine | Phenotype | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Alleles | HLA-A Antigens - genetics | Polymorphism, Single Nucleotide | Antidepressive Agents - adverse effects | Drugs | Medical research | Liver diseases | Liver | Genes | Genomics | Risk factors | Genetic polymorphisms | Analysis | Gastrointestinal diseases | Medicine, Experimental | Genetic research | Trade and professional associations | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | side effect | medication | anti-fungal agent | liver damage | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Gastroenterologi | Klinisk medicin
Journal Article
by Wang LF and Huang JW and Shan SY and Ding JH and Lai JB and Xu Y and Hu SH
Neuropsychiatric Disease and Treatment, ISSN 1178-2021, 05/2016, Volume 2016, Issue Issue 1, pp. 1127 - 1129
Lian-fang Wang,1 Jin-wen Huang,1 Si-yang Shan,2 Jia-hong Ding,3 Jian-bo Lai,1,2 Yi Xu,1,4 Shao-hua Hu1,4 1Department of Psychiatry, The First Affiliated... 
adolescents | selective serotonin reuptake inhibitors | extrapyramidal symptoms | sertraline
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 04/2008, Volume 28, Issue 2, pp. 156 - 165
Journal Article
CMAJ, ISSN 0820-3946, 11/2011, Volume 183, Issue 16, pp. 1835 - 1843
Background: Patients prescribed antiplatelet treatment to prevent recurrent acute myocardial infarction are often also given a selective serotonin reuptake... 
DEPRESSION | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | ANTIDEPRESSANTS | CLOPIDOGREL | EVENTS | PROGNOSIS | DRUGS | ELDERLY-PATIENTS | ASPIRIN | Age Factors | Anemia - epidemiology | Angioplasty | Humans | Middle Aged | Citalopram - adverse effects | Male | Risk | Secondary Prevention | Sertraline - adverse effects | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Paroxetine - adverse effects | Paroxetine - administration & dosage | Fluvoxamine - administration & dosage | Canada - epidemiology | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Retrospective Studies | Drug Therapy, Combination | Heart Failure - epidemiology | Fluoxetine - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Hemorrhage - epidemiology | Risk Factors | Serotonin Uptake Inhibitors - adverse effects | Anticoagulants - therapeutic use | Antihypertensive Agents - therapeutic use | Fluvoxamine - adverse effects | Ticlopidine - analogs & derivatives | Citalopram - administration & dosage | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Sex Factors | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Neoplasms - epidemiology | Cohort Studies | Aggregation | Complications and side effects | Blood platelets | Patient outcomes | Serotonin uptake inhibitors | Dosage and administration | Drug therapy | Hemorrhage | Heart attack | Risk factors | Studies | Side effects | Heart attacks | Inhibitor drugs | Index Medicus | Abridged Index Medicus | Research
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2006, Volume 354, Issue 12, pp. 1231 - 1242
Journal Article